About Lumea

By placing patients at the core, Lumea is transforming pathology for a more precise and efficient future.

Lumea is the U.S. leader in primary clinical digital pathology, processing the highest volume of primary digital diagnoses nationwide. With over a decade of expertise, its innovative tissue-handling technology and AI-driven workflows set a new standard for efficiency, quality, and cancer diagnostics. With a global presence spanning five continents, Lumea supports over half of the U.S. urology market and top dermatology and gastroenterology groups, optimizing tissue integrity, boosting detection rates, and delivering measurable ROI.

Meet the Lumea Leadership Team

James Thackeray

Chief Executive Officer

Mark Evans

Chief Scientific Officer

Katie Atkins

Chief Finance Officer

Chelsea Sowards

Chief Revenue Officer

Andy Ivie

Chief Innovation Officer

Bianca Collings

Executive VP of Marketing

Doug Barlow

SVP of Software Engineering

Kyron Nielsen

Vice President of Operations

Our Core Values

Humility

We strive to seek understanding, lead by serving, and celebrate others in our digital pathology company.

DaVincian Innovation

Our unique team practices DaVincian Innovation to deliver radical,
elegant, simple solutions.

Tenacity

We believe that great
things take work.
Giving up is for losers!

Quality

This is one of our greatest passions as we support those who serve patients with uncompromised quality.

Revolutionizing Diagnostic Medicine

Recognizing a Problem with Digital Pathology
Matthew Leavitt, a Stanford-trained pathologist, foresaw that digital was the future of pathology and wanted to use it in his practice. He and his colleague Jared Szymanski purchased a whole slide image scanner and some digital solutions, only to discover that they added more problems than they solved in cost and complexity. With the dream of making viable digital pathology a reality, Matt left his day job and founded the digital pathology company Lumea.

The Answer is the Tissue
Matt and the Lumea team realized that too many digital pathology solutions started at the scanner. They believed the answer lay within the tissue – starting at the point of specimen acquisition. They focused on inventing products for physicians and labs that would increase efficiency, improve patient safety, and give an actual return on investments in digital pathology.

Lumea is the Solution
Lumea’s DaVincian team developed and commercialized the most advanced digital pathology platform on the market today. Their solutions standardized and connected clinic, laboratory, and pathology workflows. This digital pathology company has deployed proprietary tissue-handling technologies, specimen tracking, laboratory efficiency improvements, a seamless digital signout process, and added invaluable AI and genetic testing partnerships to improve the quality of practices and allow businesses to scale.